Therapeutic Antibodies – Products
Whitepaper
High-Throughput, Multi-Parametric Analysis Accelerates Antibody Discovery Workflows
Download this whitepaper to discover how high-throughput flow cytometry can provide quantitative data on binding, antibody internalization and antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis and T-cell activation.
Product News
Spirea Raises £2.4M ($3M) To Develop Antibody Drug Conjugates in Cancer
Spirea Limited has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors.
App Note / Case Study
Controlling the Half-Life of Pathological IgG and Therapeutic Antibodies
Various autoimmune diseases (e.g., myasthenia gravis) are mediated by IgG autoantibodies. To address this mechanism of autoimmunity, researchers are exploring the therapeutic use of FcRn inhibitors in an effort to decrease the pathogenesis of IgG and develop new therapies.
Product News
Novel Mass Spectrometry Solution Simplifies Insight Gathering into Macromolecular Complexes
Thermo Fisher Scientific Inc. is providing proteomics and biopharmaceutical laboratories working in drug discovery and R&D applications with an innovative mass spectrometry solution that, for the first time, unlocks the ability to clearly decipher complex mixtures of large macromolecules.
Product News
Polyspecific Antibodies for Cancer Research
AMSBIO announce a new range of high-quality bispecific antibodies (BsAbs) and trispecific antibodies (TsAbs) that can used to provide enhanced cancer therapeutic efficacy and/or safety compared to what can be achieved with conventional monospecific antibodies.
Product News
Dotmatics Biology Solution for Antibody Discovery Streamlines Data Collection and Workflows
Dotmatics today announced the release of its Biology Solution for Antibody Discovery, a unique end-to-end software and data management package.
Whitepaper
Antibody Candidates Against GPCR Therapeutic Targets
Immunotherapy has the potential to treat a wide variety of conditions, from autoimmune disease to cancer. However, the discovery of potential antibody therapeutics against key receptor proteins remains a major challenge for the traditional immunisation approaches currently available on the market.
Product News
AlivaMab Discovery Services Expands Discovery Agreement with IGM Biosciences
Expanded agreement aims to accelerate the discovery of next-generation antibody modalities.
App Note / Case Study
Mannose Glycans Content Screening for Human-mAb Samples
Glycosylation refers to the formation of linkages with glycosyl groups, covalently attaching a carbohydrate to another molecule. Antibody glycosylation is critical due to the role carbohydrates play in modulating effector functions which affect safety and efficacy of therapeutic antibodies.
Product News
ACD/Labs Announces Software Updates
ACD/Labs, an informatics company that develops and commercializes software in support of R&D, has announced its annual updates across its Spectrus and Percepta platform applications.
Advertisement